S&P 5007,723.55▼0.2% Nasdaq26,363.44▼0.8% Dow54,349.12▲0.5% Russell 2K3,019.19▼0.6% 10-Yr4.62%−1bp VIX15.81−0.69 WTI$75.12▼0.9% Gold$4,308.50▲5.2% EUR/USD1.156▲0.4% BTC$64,777▲0.3% Nikkei63,958▲0.3%
At close · Wed, Aug 5, 2026
Daily Market Updates.

US Markets

Home›US Markets›M&A & Deals›Merck seen backing a takeover, as its genomics target…

Merck seen backing a takeover, as its genomics target slips

Friday, July 17, 2026 · Written up by our desk · M&A & Deals

Yahoo Finance reports that Merck is reportedly taking a more active role in a takeover battle.

The same report says the target’s genomics stock reversed course after the news, indicating market sensitivity around the deal dynamics.

← Newer storyNasdaq and AI stocks weigh on US shares in weekly review

More like this

US MarketsSpaceX lockup expiration frees 911.5M shares, boosting daily eligible float
US MarketsFox will not renegotiate NFL media rights until after 2030 opt-out
US MarketsEasyJet agrees £5.7bn takeover after rival Castlelake drops bid
US MarketsDiageo plans to double Guinness capacity through turnaround
US MarketsAccell launches insolvency proceedings for bike brand Raleigh

Sources

Yahoo FinanceMerck Reportedly Goes To Bat In Takeover Battle. But Genomics Stock Reverses.

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.